Free tool
Heavily traded stocks
We cover 157 companies whose typical session turns over more than $10.00M. The median market value in the group is $27.39B. Across the group, the median move over the past trading day is −0.09%. 74% of the 156 with a 200-day average trade above it. Price change over the past year runs from −15.6% to +94.0% across the middle 80 percent of the group, with a median of +25.6%.
Other lists in this group
Table
157 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1,189.41 | −2.56% | +10.47% | +62.80% |
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% |
| ABBV | AbbVie Inc. | $262.90 | −0.11% | +16.53% | +29.36% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| NVS | Novartis AG | $157.54 | −1.45% | +17.18% | +27.93% |
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% |
| AZN | AstraZeneca PLC | $166.27 | −3.60% | −8.27% | +5.09% |
| AZN.ST | AstraZeneca PLC | 1,609.00 SEK | −4.94% | −4.94% | +6.22% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| NOVO-B.CO | Novo Nordisk A/S | 307.80 DKK | −8.95% | −3.58% | −11.26% |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% |
| NVO | Novo Nordisk A/S | $47.19 | −7.40% | −6.62% | −13.32% |
| ABT | Abbott Laboratories | $114.10 | +6.37% | −7.08% | −11.83% |
| GILD | Gilead Sciences, Inc. | $148.09 | +10.25% | +22.48% | +32.51% |
| PFE | Pfizer Inc. | $28.30 | +12.08% | +16.16% | +18.72% |
| DHR | Danaher Corporation | $215.36 | +8.19% | −6.33% | +5.61% |
| VRTX | Vertex Pharmaceuticals Incorporated | $547.29 | +11.60% | +21.05% | +40.66% |
| BMY | Bristol-Myers Squibb Company | $67.57 | +6.24% | +27.70% | +47.01% |
| ISRG | Intuitive Surgical, Inc. | $370.42 | +2.38% | −34.09% | −21.38% |
| SYK | Stryker Corporation | $329.67 | −4.88% | −5.06% | −15.52% |
| MDT | Medtronic plc | $92.02 | +5.92% | −3.41% | +2.29% |
| SAN.PA | Sanofi | 78.74 EUR | −1.48% | +1.00% | −2.60% |
| SNY | Sanofi | $45.42 | −0.26% | −0.60% | −4.33% |
| MCK | McKesson Corporation | $896.65 | +0.80% | +8.98% | +31.57% |
| GSK | GSK plc | $51.43 | −4.25% | +5.41% | +32.23% |
| GSK.L | GSK plc | 1,905.50 GBP | −5.06% | +4.06% | +30.59% |
| HCA | HCA Healthcare, Inc. | $427.16 | +2.14% | −9.06% | +5.96% |
| ELV | Elevance Health, Inc. | $402.54 | +4.36% | +14.33% | +32.12% |
| EL.PA | EssilorLuxottica Société anonyme | 159.15 EUR | −3.60% | −38.64% | −38.15% |
| REGN | Regeneron Pharmaceuticals, Inc. | $814.79 | +17.21% | +5.24% | +39.36% |
| CI | The Cigna Group | $280.87 | −6.71% | +1.18% | −4.84% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | 6,953.00 JPY | −1.64% | −18.35% | +9.21% |
| MRK.DE | Merck KGaA | 139.35 EUR | −3.96% | +17.18% | +32.17% |
| BSX | Boston Scientific Corporation | $48.17 | +4.58% | −49.14% | −54.50% |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% |
| COR | Cencora, Inc. | $327.79 | +2.57% | −2.88% | +13.45% |
| MRNA | Moderna, Inc. | $149.66 | +168.18% | +384.96% | +496.25% |
| CSL.AX | CSL Limited | 173.59 AUD | +35.54% | +2.25% | −16.37% |
| TAK | Takeda Pharmaceutical Company Limited | $18.23 | +4.05% | +16.71% | +22.68% |
| 4502.T | Takeda Pharmaceutical Company Limited | 5,791.00 JPY | −0.96% | +19.85% | +36.03% |
| BAYN.DE | Bayer Aktiengesellschaft | 49.26 EUR | +3.29% | +30.00% | +76.91% |
| CAH | Cardinal Health, Inc. | $238.40 | +2.53% | +16.17% | +61.05% |
| 207940.KS | Samsung Biologics Co.,Ltd. | 1,589,000.00 KRW | +7.44% | −5.59% | +2.12% |
| EW | Edwards Lifesciences Corporation | $90.78 | +8.48% | +6.39% | +12.21% |
| BDX | Becton, Dickinson and Company | $190.21 | +14.35% | +24.91% | +25.97% |
| 7741.T | HOYA Corporation | 24,525.00 JPY | +3.20% | +2.32% | +28.99% |
| SHL.DE | Siemens Healthineers AG | 39.70 EUR | +5.75% | −7.90% | −14.18% |
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% |
| HUM | Humana Inc. | $391.06 | +0.60% | +48.61% | +33.14% |
| MDLN | Medline Inc. | $35.64 | −12.02% | −12.26% | −13.07% |
| RVMD | Revolution Medicines, Inc. | $215.44 | +17.18% | +172.64% | +466.35% |
| HLN | Haleon plc | $10.17 | −0.97% | +3.05% | +6.13% |
| HLN.L | Haleon plc | 369.60 GBP | −2.66% | −0.12% | +2.68% |
| TEVA | Teva Pharmaceutical Industries Limited | $37.92 | +19.73% | +22.52% | +110.08% |
| A | Agilent Technologies, Inc. | $155.08 | +10.35% | +12.88% | +31.46% |
| IDXX | IDEXX Laboratories, Inc. | $553.44 | −2.83% | −17.40% | −13.64% |
| IQV | IQVIA Holdings Inc. | $261.51 | +7.64% | +16.04% | +38.51% |
| ONC | BeOne Medicines AG | $375.80 | +13.72% | +20.83% | +25.21% |
| WAT | Waters Corporation | $414.17 | +7.88% | +8.43% | +40.57% |
| 4578.T | Otsuka Holdings Co., Ltd. | 12,260.00 JPY | +6.56% | +35.48% | +57.62% |
| VEEV | Veeva Systems Inc. | $244.91 | +21.72% | +11.58% | −16.58% |
| RPRX | Royalty Pharma plc | $61.80 | +3.05% | +60.57% | +74.00% |
| ALC | Alcon Inc. | $72.67 | +5.15% | −5.89% | −10.24% |
| RMD | ResMed Inc. | $235.69 | +12.79% | −3.22% | −15.77% |
| RMD.AX | ResMed Inc. | 32.47 AUD | +8.27% | −9.89% | −24.75% |
| ILMN | Illumina, Inc. | $224.84 | +16.51% | +67.35% | +125.88% |
| DXCM | DexCom, Inc. | $88.96 | +18.85% | +33.69% | +16.47% |
| GEHC | GE HealthCare Technologies Inc. | $73.31 | +14.35% | −11.40% | −1.15% |
| 4568.T | Daiichi Sankyo Company, Limited | 2,874.50 JPY | −0.42% | −17.47% | −17.94% |
| BIIB | Biogen Inc. | $221.07 | +7.52% | +24.32% | +62.12% |
| CNC | Centene Corporation | $65.47 | +2.44% | +56.70% | +127.01% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $239.00 | −17.13% | −40.28% | −47.38% |
| ZTS | Zoetis Inc. | $77.52 | +0.01% | −37.91% | −49.50% |
| 068270.KS | Celltrion, Inc. | 190,900.00 KRW | +6.06% | −5.73% | +11.19% |
| FRE.DE | Fresenius SE & Co. KGaA | 45.85 EUR | +2.98% | −1.28% | +1.64% |
| BNTX | BioNTech SE | $112.56 | +21.75% | +16.41% | +9.27% |
| MTD | Mettler-Toledo International Inc. | $1,398.46 | +0.73% | −0.92% | +8.81% |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% |
| INSM | Insmed Incorporated | $124.39 | +19.46% | −29.77% | −7.54% |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% |
| 4503.T | Astellas Pharma Inc. | 2,392.50 JPY | +4.23% | +14.03% | +53.57% |
| ROIV | Roivant Sciences Ltd. | $36.75 | +8.60% | +67.58% | +206.51% |
| PHG | Koninklijke Philips N.V. | $26.99 | +5.64% | +3.59% | +1.27% |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% |
| WST | West Pharmaceutical Services, Inc. | $349.92 | +3.90% | +26.81% | +42.61% |
| 4543.T | Terumo Corporation | 2,557.50 JPY | +7.35% | +13.84% | −2.68% |
| STE | STERIS plc | $236.77 | +2.79% | −5.07% | −4.41% |
| GH | Guardant Health, Inc. | $170.92 | +19.01% | +68.00% | +169.17% |
| THC | Tenet Healthcare Corporation | $274.19 | +4.40% | +37.47% | +50.70% |
| DIM.PA | Sartorius Stedim Biotech S.A. | 194.30 EUR | +13.49% | −6.30% | +11.64% |
| SIG.AX | Sigma Healthcare Limited | 2.59 AUD | −13.09% | −11.26% | −15.21% |
| GMAB | Genmab A/S | $33.75 | +16.38% | +6.07% | +36.20% |
| GMAB.CO | Genmab A/S | 2,196.00 DKK | +17.62% | +9.42% | +36.19% |
| SRT3.DE | Sartorius Aktiengesellschaft | 246.50 EUR | +9.26% | −0.18% | +25.88% |
| VTRS | Viatris Inc. | $16.85 | −5.66% | +37.39% | +66.19% |
| ZBH | Zimmer Biomet Holdings, Inc. | $101.38 | +5.88% | +12.93% | −4.32% |
| MEDP | Medpace Holdings, Inc. | $619.05 | +8.42% | +8.41% | +30.74% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% |
| JAZZ | Jazz Pharmaceuticals plc | $249.29 | −2.97% | +43.97% | +100.35% |
| ASND | Ascendis Pharma A/S | $250.25 | −1.65% | +17.33% | +29.66% |
| IPN.PA | Ipsen S.A. | 166.00 EUR | +1.41% | +42.98% | +40.80% |
| COLO-B.CO | Coloplast A/S | 462.50 DKK | +6.22% | −12.68% | −20.60% |
| NBIX | Neurocrine Biosciences, Inc. | $156.59 | −14.35% | +11.37% | +13.36% |
| SOLV | Solventum Corporation | $91.53 | +6.22% | +15.83% | +25.57% |
| BBIO | BridgeBio Pharma, Inc. | $79.37 | −7.22% | +1.45% | +60.05% |
| 4507.T | Shionogi & Co., Ltd. | 2,892.00 JPY | −5.80% | +2.05% | +15.63% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | 36.47 AUD | +5.19% | +12.67% | +11.27% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | 35.30 BRL | +2.86% | −12.41% | +1.37% |
| ERF.PA | Eurofins Scientific SE | 74.08 EUR | +7.93% | +20.90% | +15.60% |
| 7733.T | Olympus Corporation | 2,162.50 JPY | +16.11% | +8.42% | +27.06% |
| COO | The Cooper Companies, Inc. | $72.68 | +0.86% | −10.39% | −1.93% |
| CRL | Charles River Laboratories International, Inc. | $295.10 | +22.74% | +45.79% | +81.27% |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% |
| RVTY | Revvity, Inc. | $126.35 | +13.31% | +28.91% | +42.93% |
| BAX | Baxter International Inc. | $26.50 | +8.74% | +35.96% | +8.90% |
| PME.AX | Pro Medicus Limited | 181.86 AUD | +10.93% | −18.09% | −39.15% |
| ORNBV.HE | Orion Oyj | 80.80 EUR | −1.76% | +29.38% | +21.01% |
| ICLR | ICON Public Limited Company | $168.93 | −6.27% | −10.46% | −2.91% |
| CORT | Corcept Therapeutics Incorporated | $119.80 | +27.19% | +213.61% | +71.81% |
| PEN | Penumbra, Inc. | $323.05 | +0.96% | +4.41% | +21.02% |
| BMRN | BioMarin Pharmaceutical Inc. | $65.61 | +5.70% | +10.36% | +11.85% |
| FME.DE | Fresenius Medical Care AG | 40.36 EUR | −7.39% | +4.49% | −2.61% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | 52.70 EUR | +2.53% | +10.68% | +1.80% |
| ELAN | Elanco Animal Health Incorporated | $25.08 | −1.72% | +11.37% | +35.64% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $89.12 | +3.89% | +31.46% | +308.99% |
| FMS | Fresenius Medical Care AG | $23.40 | −5.45% | +3.54% | −3.21% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $538.88 | +0.01% | −9.26% | +26.78% |
| HALO | Halozyme Therapeutics, Inc. | $107.06 | +28.29% | +52.27% | +46.30% |
| TEM | Tempus AI, Inc. | $68.48 | +59.63% | +9.81% | −6.49% |
| SNN | Smith & Nephew plc | $29.30 | −10.01% | −9.54% | −19.49% |
| SN.L | Smith & Nephew plc | 1,068.00 GBP | −12.06% | −12.27% | −22.42% |
| EHC | Encompass Health Corporation | $120.78 | +4.09% | +13.77% | −1.75% |
| DVA | DaVita Inc. | $180.05 | −24.81% | +57.24% | +30.89% |
| SMMT | Summit Therapeutics Inc. | $14.23 | +13.39% | −18.78% | −42.63% |
| TECH | Bio-Techne Corporation | $72.38 | +0.43% | +21.73% | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $61.35 | −15.33% | +59.77% | +156.37% |
| ALGN | Align Technology, Inc. | $159.14 | −9.37% | +1.99% | +12.09% |
| GMED | Globus Medical, Inc. | $83.10 | +3.13% | −4.81% | +35.10% |
| CYTK | Cytokinetics, Incorporated | $79.20 | −0.31% | +28.30% | +109.36% |
| AXSM | Axsome Therapeutics, Inc. | $207.15 | −11.55% | +15.93% | +69.99% |
| GKOS | Glaukos Corporation | $180.57 | +19.32% | +63.09% | +89.83% |
| KRYS | Krystal Biotech, Inc. | $359.76 | −1.23% | +45.70% | +143.67% |
| MOH | Molina Healthcare, Inc. | $199.63 | −0.35% | +11.86% | +13.35% |
| IONS | Ionis Pharmaceuticals, Inc. | $63.36 | +14.58% | −20.47% | +48.21% |
| PRAX | Praxis Precision Medicines, Inc. | $377.37 | +27.57% | +31.76% | +704.28% |
| UHS | Universal Health Services, Inc. | $178.69 | +7.50% | −18.65% | −1.76% |
| KYMR | Kymera Therapeutics, Inc. | $125.55 | +18.26% | +72.55% | +197.09% |
| ENSG | The Ensign Group, Inc. | $180.63 | −1.37% | +3.89% | +5.01% |
| BIO | Bio-Rad Laboratories, Inc. | $388.64 | +17.41% | +27.31% | +32.71% |
| HSIC | Henry Schein, Inc. | $90.38 | +5.45% | +17.65% | +31.02% |
| RGEN | Repligen Corporation | $180.30 | +24.05% | +9.70% | +51.67% |
| BIM.PA | bioMérieux S.A. | 75.50 EUR | +3.64% | −31.05% | −35.91% |
| APGE | Apogee Therapeutics, Inc. | $134.95 | +0.58% | +78.08% | +257.11% |
| ABVX.PA | ABIVAX Société Anonyme | 102.30 EUR | −5.63% | −11.04% | +48.91% |
| RDY | Dr. Reddy's Laboratories Limited | $12.22 | +4.18% | −11.83% | −14.19% |
| ABVX | ABIVAX Société Anonyme | $116.52 | −6.21% | −12.90% | +46.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.